Exact Mass: 408.32528

Exact Mass Matches: 408.32528

Found 84 metabolites which its exact mass value is equals to given mass value 408.32528, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Linoleoyl Lysine

6-amino-2-(octadeca-9,12-dienamido)hexanoic acid

C24H44N2O3 (408.3351754)


N-linoleoyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Lysine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   
   
   
   

8beta,15-dihydroxy-18-angeloyloxy-ent-labdane

8beta,15-dihydroxy-18-angeloyloxy-ent-labdane

C25H44O4 (408.3239424)


   
   
   
   

8beta,15-dihydroxy-18-senecioyloxy-ent-labdane

8beta,15-dihydroxy-18-senecioyloxy-ent-labdane

C25H44O4 (408.3239424)


   

CID 25212181

2-(chloromethyl)oxirane,N,N,N,N-tetrakis(3-aminopropyl)butane-1,4-diamine

C19H45ClN6O (408.334319)


   
   
   

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] butanoate

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] butanoate

C25H44O4 (408.3239424)


   

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] acetate

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] acetate

C25H44O4 (408.3239424)


   

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] hexanoate

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] hexanoate

C25H44O4 (408.3239424)


   

2,3-dihydroxypropyl (10Z,13Z,16Z)-docosa-10,13,16-trienoate

2,3-dihydroxypropyl (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C25H44O4 (408.3239424)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

DG(22:3)

DG(12:0(1)_10:3)

C25H44O4 (408.3239424)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

FAHFA 10:0/O-15:2

FAHFA 10:0/O-15:2

C25H44O4 (408.3239424)


   

FAHFA 10:1/O-15:1

FAHFA 10:1/O-15:1

C25H44O4 (408.3239424)


   

FAHFA 10:2/O-15:0

FAHFA 10:2/O-15:0

C25H44O4 (408.3239424)


   

FAHFA 11:0/O-14:2

FAHFA 11:0/O-14:2

C25H44O4 (408.3239424)


   

FAHFA 11:1/O-14:1

FAHFA 11:1/O-14:1

C25H44O4 (408.3239424)


   

FAHFA 11:2/O-14:0

FAHFA 11:2/O-14:0

C25H44O4 (408.3239424)


   

FAHFA 12:0/O-13:2

FAHFA 12:0/O-13:2

C25H44O4 (408.3239424)


   

FAHFA 12:1/O-13:1

FAHFA 12:1/O-13:1

C25H44O4 (408.3239424)


   

FAHFA 12:2/O-13:0

FAHFA 12:2/O-13:0

C25H44O4 (408.3239424)


   

FAHFA 13:0/O-12:2

FAHFA 13:0/O-12:2

C25H44O4 (408.3239424)


   

FAHFA 13:1/O-12:1

FAHFA 13:1/O-12:1

C25H44O4 (408.3239424)


   

FAHFA 13:2/O-12:0

FAHFA 13:2/O-12:0

C25H44O4 (408.3239424)


   

FAHFA 14:0/O-11:2

FAHFA 14:0/O-11:2

C25H44O4 (408.3239424)


   

FAHFA 14:1/O-11:1

FAHFA 14:1/O-11:1

C25H44O4 (408.3239424)


   

FAHFA 14:2/O-11:0

FAHFA 14:2/O-11:0

C25H44O4 (408.3239424)


   

FAHFA 15:0/O-10:2

FAHFA 15:0/O-10:2

C25H44O4 (408.3239424)


   

FAHFA 15:1/O-10:1

FAHFA 15:1/O-10:1

C25H44O4 (408.3239424)


   

FAHFA 15:2/O-10:0

FAHFA 15:2/O-10:0

C25H44O4 (408.3239424)


   
   
   
   
   
   
   

FAHFA 19:2(10Z,13Z)/3O-6:0

FAHFA 19:2(10Z,13Z)/3O-6:0

C25H44O4 (408.3239424)


   
   
   
   
   
   
   
   
   
   

(2s,3as,6ar)-6-decylidene-3a-methyl-2-nonyl-dihydrofuro[2,3-d][1,3]dioxol-5-one

(2s,3as,6ar)-6-decylidene-3a-methyl-2-nonyl-dihydrofuro[2,3-d][1,3]dioxol-5-one

C25H44O4 (408.3239424)


   

methyl (2s)-2-[(3r,6s)-6-[6-(2,2-dimethyl-6-methylidenecyclohexyl)-4-methylhexyl]-6-methyl-1,2-dioxan-3-yl]propanoate

methyl (2s)-2-[(3r,6s)-6-[6-(2,2-dimethyl-6-methylidenecyclohexyl)-4-methylhexyl]-6-methyl-1,2-dioxan-3-yl]propanoate

C25H44O4 (408.3239424)


   

methyl (2s)-2-[(3r,6s)-6-methyl-6-[(4s)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-1,2-dioxan-3-yl]propanoate

methyl (2s)-2-[(3r,6s)-6-methyl-6-[(4s)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-1,2-dioxan-3-yl]propanoate

C25H44O4 (408.3239424)


   

[6-hydroxy-5-(5-hydroxy-3-methylpentyl)-1,4a,6-trimethyl-hexahydro-2h-naphthalen-1-yl]methyl 3-methylbut-2-enoate

[6-hydroxy-5-(5-hydroxy-3-methylpentyl)-1,4a,6-trimethyl-hexahydro-2h-naphthalen-1-yl]methyl 3-methylbut-2-enoate

C25H44O4 (408.3239424)


   

[(1s,4ar,5s,6s,8as)-6-hydroxy-5-[(3s)-5-hydroxy-3-methylpentyl]-1,4a,6-trimethyl-hexahydro-2h-naphthalen-1-yl]methyl 3-methylbut-2-enoate

[(1s,4ar,5s,6s,8as)-6-hydroxy-5-[(3s)-5-hydroxy-3-methylpentyl]-1,4a,6-trimethyl-hexahydro-2h-naphthalen-1-yl]methyl 3-methylbut-2-enoate

C25H44O4 (408.3239424)


   

(4s,5r,6r)-4,5,6-trihydroxy-6-(nonadec-10-en-1-yl)cyclohex-2-en-1-one

(4s,5r,6r)-4,5,6-trihydroxy-6-(nonadec-10-en-1-yl)cyclohex-2-en-1-one

C25H44O4 (408.3239424)


   

pentacosane-6,10,16,20-tetrone

pentacosane-6,10,16,20-tetrone

C25H44O4 (408.3239424)


   

(2s,3as,6e,6ar)-6-decylidene-3a-methyl-2-nonyl-dihydrofuro[2,3-d][1,3]dioxol-5-one

(2s,3as,6e,6ar)-6-decylidene-3a-methyl-2-nonyl-dihydrofuro[2,3-d][1,3]dioxol-5-one

C25H44O4 (408.3239424)


   

(4s,5r,6r)-4,5,6-trihydroxy-6-[(10z)-nonadec-10-en-1-yl]cyclohex-2-en-1-one

(4s,5r,6r)-4,5,6-trihydroxy-6-[(10z)-nonadec-10-en-1-yl]cyclohex-2-en-1-one

C25H44O4 (408.3239424)


   

[(1s,4ar,5s,6s,8as)-6-hydroxy-5-[(3s)-5-hydroxy-3-methylpentyl]-1,4a,6-trimethyl-hexahydro-2h-naphthalen-1-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,4ar,5s,6s,8as)-6-hydroxy-5-[(3s)-5-hydroxy-3-methylpentyl]-1,4a,6-trimethyl-hexahydro-2h-naphthalen-1-yl]methyl (2z)-2-methylbut-2-enoate

C25H44O4 (408.3239424)


   

[6-hydroxy-5-(5-hydroxy-3-methylpentyl)-1,4a,6-trimethyl-hexahydro-2h-naphthalen-1-yl]methyl 2-methylbut-2-enoate

[6-hydroxy-5-(5-hydroxy-3-methylpentyl)-1,4a,6-trimethyl-hexahydro-2h-naphthalen-1-yl]methyl 2-methylbut-2-enoate

C25H44O4 (408.3239424)


   

methyl (2s)-2-[(3r,6s)-6-[(4s)-6-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-4-methylhexyl]-6-methyl-1,2-dioxan-3-yl]propanoate

methyl (2s)-2-[(3r,6s)-6-[(4s)-6-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-4-methylhexyl]-6-methyl-1,2-dioxan-3-yl]propanoate

C25H44O4 (408.3239424)


   

methyl (2r)-2-[(3s,6r)-6-[(4s)-6-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-4-methylhexyl]-6-methyl-1,2-dioxan-3-yl]propanoate

methyl (2r)-2-[(3s,6r)-6-[(4s)-6-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-4-methylhexyl]-6-methyl-1,2-dioxan-3-yl]propanoate

C25H44O4 (408.3239424)


   

3-[(3-{[(9z,12z)-1-hydroxyoctadeca-9,12-dien-1-ylidene]amino}propyl)amino]propanoic acid

3-[(3-{[(9z,12z)-1-hydroxyoctadeca-9,12-dien-1-ylidene]amino}propyl)amino]propanoic acid

C24H44N2O3 (408.3351754)


   

3-({3-[(1-hydroxyoctadeca-9,12-dien-1-ylidene)amino]propyl}amino)propanoic acid

3-({3-[(1-hydroxyoctadeca-9,12-dien-1-ylidene)amino]propyl}amino)propanoic acid

C24H44N2O3 (408.3351754)


   

methyl (2s)-2-[(3r,6s)-6-methyl-6-[4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-1,2-dioxan-3-yl]propanoate

methyl (2s)-2-[(3r,6s)-6-methyl-6-[4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-1,2-dioxan-3-yl]propanoate

C25H44O4 (408.3239424)


   

methyl (2r)-2-[(3s,6r)-6-methyl-6-[(4s)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-1,2-dioxan-3-yl]propanoate

methyl (2r)-2-[(3s,6r)-6-methyl-6-[(4s)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-1,2-dioxan-3-yl]propanoate

C25H44O4 (408.3239424)